Zobrazeno 1 - 10
of 112
pro vyhledávání: '"Thomas Ervin"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Cabaniss, Thomas Ervin
Publikováno v:
Theological Research Exchange Network (TREN): Theses & Dissertations. 2001, p1-236. 236p.
Autor:
Jiping Zha, Rodryg Ramlau, J. Goldschmidt, David R. Spigel, Maciej Krzakowski, Benoit Godbert, Gilles Robinet, Michael S. Wertheim, George R. Blumenschein, Thomas Ervin, Robert L. Yauch, Premal Patel, Fabrice Barlesi, Ramaswamy Govindan, Wei Yu, Sergey Orlov, Amy C. Peterson, Taral Patel, See Chun Phan, Davey B. Daniel
Publikováno v:
Journal of Clinical Oncology. 31:4105-4114
Purpose Increased hepatocyte growth factor/MET signaling is associated with poor prognosis and acquired resistance to epidermal growth factor receptor (EGFR) –targeted drugs in patients with non–small-cell lung cancer (NSCLC). We investigated whe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3024fb24b642f42b1d3093fde13e00d
https://doi.org/10.1200/jco.2012.47.4189
https://doi.org/10.1200/jco.2012.47.4189
Autor:
György Losonczy, David R. Spigel, Weilan Ye, Thomas Ervin, Fabrice Barlesi, Ina Rhee, Eric Wakshull, Maria Anderson, E. Juhasz, Priti S. Hegde, Joachim von Pawel, Martin Reck, Ilsung Chang, Daniel S. Chen, Bruce McCall
Publikováno v:
The Oncologist
Lessons LearnedThe lack of efficacy associated with anti-EGFL7 combined with standard bevacizumab and chemotherapy in this phase II trial in non-small cell lung carcinoma is consistent with the lack of benefit observed in colorectal carcinoma, highli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a2bb5bc3f27fe8a3392dbec3840127f
https://doi.org/10.1634/theoncologist.2017-0690
https://doi.org/10.1634/theoncologist.2017-0690
Autor:
David W. Baker, Thomas Ervin
Publikováno v:
Wiley Encyclopedia of Forensic Science
Network analysis is a challenging area of digital forensics, which can provide substantive data to assist in the investigation of network-based events. There are several key challenge areas, and a variety of tools and techniques that can be utilized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3bf7959b13edc323f49b8de168f9d693
https://doi.org/10.1002/9780470061589.fsa447
https://doi.org/10.1002/9780470061589.fsa447
Autor:
Schneider, Thomas Ervin
This study shows an economically significant relation between a firm’s environmental performance and its cost of debt. Firms that have poor environmental performance will face future environmental liabilities related to compliance and clean-up cost
Externí odkaz:
http://hdl.handle.net/10012/3962
Autor:
Thomas Ervin, J. Daniel Cuevas, Ian W. Flinn, Ralph V. Boccia, Dianna Shipley, Jesus G. Berdeja, Douglas Flora, D. S. Thompson
Publikováno v:
Blood. 126:1492-1492
Introduction: Rituximab and bendamustine combination regimens have demonstrated high activity in non-Hodgkin's lymphoma (NHL). Phase III trials evaluating bendamustine plus rituximab as first-line therapy for patients (pts) with indolent and mantle c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f57d18b0c370899d3f9f13dc3966681d
https://doi.org/10.1182/blood.v126.23.1492.1492
https://doi.org/10.1182/blood.v126.23.1492.1492
Autor:
Elena G. Chiorean, Alfredo Romano, Malcolm A.S. Moore, Colin D. Weekes, Sunil R. Hingorani, Francis P. Arena, Daniel D. Von Hoff, Vinod Ganju, Ramesh K. Ramanathan, Thomas Ervin, David Goldstein, Xinyu Wei, Josep Tabernero, Jeffrey R. Infante, Werner Scheithauer
Publikováno v:
Annals of Oncology. 24:iv11-iv12
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b4fd4fc69f0e54e3bf628ba5406d831
https://doi.org/10.1093/annonc/mdt201.1
https://doi.org/10.1093/annonc/mdt201.1
Autor:
Cabaniss, Thomas Ervin.
Publikováno v:
Online full text .pdf document, available to Fuller patrons only..
Thesis (D. Min.)--Reformed Theological Seminary, (Charlotte, SC), 2001.
Includes bibliographical references (leaves 228-236).
Includes bibliographical references (leaves 228-236).
Externí odkaz:
http://proxy.fuller.edu:2048/login?url=http://libraryweb.fuller.edu/tren/083-0002.pdf
Autor:
Michael Mauro, Jerald Radich, Jorge E. Cortes, Shaker Dakhil, Christopher Keir, Sandy Yi, Martha Wadleigh, Vivian G. Oehler, Thomas Ervin, Stuart Goldberg, Michael Savona
Publikováno v:
Blood. 122:4015-4015
Background Pivotal treatment-free remission (TFR) trials require prolonged deep molecular response (MR), often MR4.5, for study entry (Mahon et al. 2010), which has led to increasing focus on MR4.5 as a treatment goal for pts with CML-CP. New tyrosin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f1733aabf34514f36c564ec952371d0
https://doi.org/10.1182/blood.v122.21.4015.4015
https://doi.org/10.1182/blood.v122.21.4015.4015